EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Expert Opinion on Biological Therapy

ISSN 1471-2598 · Informa UK Limited

Latest articles

  1. Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis

    Kannan Sridharan, Ondrej Fiala, Gowri Sivaramakrishnan, Marc R. Matrana, Thomas Büttner, Jakub Kucharz, Javier Molina Cerrillo, Patrizia Giannatempo, Zin W. Myint, Alfonso Gómez de Liaño, Alina Pirshtuk, Augusto Mota, Ravindran Kanesvaran, Yüksel Ürün, Martin Angel, Tomas Soule, Francesco Massari, Joaquim Bellmunt, Shilpa Gupta, Matteo Santoni

    Published: 2026-10-03DOI: 10.1080/14712598.2026.2727098

  2. Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort

    Francesco Caso, Eleonora Celletti, Ilenia Pantano, Francesco Maria Mariani, Azadeh Shariat Panahi, Myriam Di Penta, Riccardo Mattia Ricciardi, Alberto Lo Gullo, Daniele Mauro, Francesca Saracino, Francesco Ursini, Luisa Costa, Raffaele Scarpa, Roberto Giacomelli, Francesco Ciccia, Giuliana Guggino, Paola Cipriani, Piero Ruscitti

    Published: 2026-10-03DOI: 10.1080/14712598.2026.2736542

Volumes

2026 · 1302025 · 1272024 · 1332023 · 1312022 · 1432021 · 1532020 · 1492019 · 1282018 · 1552017 · 1472016 · 1422015 · 1912014 · 1752013 · 1782012 · 1892011 · 1432010 · 1492009 · 1432008 · 1722007 · 1632006 · 1182005 · 1412004 · 2492003 · 2302002 · 912001 · 85

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.